Publication date: Jul 13, 2023
Telemedicine for pediatric lower urinary tract symptoms (pLUTS) is a relatively new mode of delivering bladder health education with scant evidence supporting current practice. We aim to examine the safety of pLUTS-related telemedicine visits surrounding the COVID-19 pandemic. We conducted a retrospective cohort study of new pLUTS referral diagnoses to our institution’s pediatric urology clinics. Demographics, wait times, and referral diagnoses were captured and compared before and after March 2020 using χ /Fisher exact tests and t-tests. A retrospective chart review was performed for an initial telemedicine visit followed by an in-person visit to identify missed radiology, lab, or physical exam findings. Six hundred twelve patients were included from September 2018 to August 2021. Most were 5-10 years old (62. 3%), female (56. 2%), English speaking (86. 5%), White (39. 4%), and had private insurance (67. 2%). Wait times were shorter for telemedicine versus in-person visits (t = -3. 56, p
| Concepts | Keywords |
|---|---|
| 10years | child health |
| August | pediatrics |
| Covid | telemedicine |
| Education | urology |
| Urology |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 pandemic |